Navigation Links
Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO

Tanespimycin TIME Registration Program to Begin Third Quarter 2007

HAYWARD, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated presented data from a dose-escalating Phase 1b clinical trial of its lead Hsp90 inhibitor, tanespimycin (KOS-953) in combination with bortezomib (Velcade(R)), showing a high degree of antitumor activity and tolerability in patients with multiple myeloma who had previously progressed following treatment with multiple conventional therapies. The data were presented on Saturday, June 2, 2007, by Paul Richardson, M.D., Department of Hematology, Dana Farber Cancer Center, Boston, MA, in a poster titled "A Multicenter Phase 1 Clinical Trial of Tanespimycin (KOS-953) + Bortezomib in Relapsed Refractory Multiple Myeloma" at the 2007 Annual Meeting of the American Society of Clinical Oncology (ASCO).

"Tanespimycin has significant potential as a new treatment for patients with multiple myeloma and is promising in patients with refractory disease whose need for new therapeutic options is especially important," said Dr. Richardson. "The overall profile of tanespimycin in terms of antitumor activity and tolerability, with no additive toxicity to bortezomib, is attractive and we are excited to be moving into later-stage clinical development."

"With the initiation of our TIME clinical program later this year, utilizing our new, superior injectable suspension formulation, tanespimycin will be the first Hsp90 inhibitor to enter registration trials and has the potential to be the first Hsp90 inhibitor to reach the market," said Robert G. Johnson, Jr., M.D., Ph.D., Kosan's President and Chief Executive Officer. "We are highly encouraged by the level of tanespimycin's activity in multiple myeloma and its tolerability and safety profile, and believe that tanespimycin has the potential to represent a breakthrough in the treatment of multiple myeloma. We appreciate th
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
4. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:8/22/2014)... 22, 2014 Research and Markets ... Chinese Intravenous Catheter Industry Report 2014" report to ... Intravenous Catheter Industry Report 2014 is a professional and ... intravenous catheter industry with a focus on the Chinese ... the industry including definitions, classifications, applications and industry chain ...
(Date:8/22/2014)... Aug. 22, 2014  Mark Riccio, director of ... facility, is using the online crowd-funding platform Kickstarter ... imaging to researchers and would-be superheros everywhere: "for ... would YOU do if you had Superman,s X-ray ... and explorers everywhere, from elementary through high school ...
(Date:8/22/2014)... - SQI Diagnostics Inc. (TSX-V: SQD), a life ... and products for advanced microarray diagnostics, today announced ... Agreement to contract with a UK-based company to ... initial phase of this agreement, SQI will be ... one of the customer,s assays, operational on SQI,s ...
Breaking Medicine Technology:Global and Chinese Intravenous Catheter Industry Report 2014 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... Jan. 26, 2011 QPS, LLC, a leading full-service ... preclinical and clinical research and development, announced the acquisition ... a full service phase 1 CRO headquartered in Hyderabad, ... QPS is a global CRO supporting drug discovery and ...
... FORT WORTH, Texas, Jan. 26, 2011 Wound Management ... an emerging leader in advanced wound care solutions, announced ... provider, Secure eHealth will be included in a technology ... Conference February 21st-24th at the Orange County Convention Center ...
Cached Medicine Technology:QPS Expands Phase 1 and Bioanalytical Capability by Acquisition of Bioserve, India 2Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase 2Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase 3Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase 4
(Date:8/22/2014)... Indiana (PRWEB) August 22, 2014 The ... Toyota Indiana is on the grow again. ... 300 jobs by summer 2016 to boost production of ... will bring Toyota Indiana’s overall investment to $4 billion. ... North America while providing additional flexibility to adjust its ...
(Date:8/22/2014)... - A Penn Medicine team has found that ... reduce urinary tract infections in hospital patients with ... the alert was simplified, the rate of improvement ... whether their patients need urinary catheters in the ... the need for catheters that have not been ...
(Date:8/22/2014)... 22, 2014 (HealthDay News) -- Many Americans know little about ... possibility of an outbreak in the United States, a new ... are worried that there will be a major Ebola outbreak ... or an immediate family member will get sick with the ... Harvard School of Public Health poll. However, those opinions ...
(Date:8/22/2014)... Millennium Treatment Group, a drug ... recently launched a new website. Patients, parents, loved ... now find Millennium Treatment Group at http://www.millenniumtreatmentgroup.com ... at the beginning of July. Everything anyone would ... found on the website. There’s an About Us ...
(Date:8/22/2014)... 2014 Beat Eczema , Susan ... use natural methods to completely cure the eczema symptoms ... of Shane Michaels, prompting an investigative review. , ... skin, it can still be extremely debilitating and life-altering ... intense itching and pain that it causes on the ...
Breaking Medicine News(10 mins):Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Millennium Treatment Group Has a New Website 2Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2
... to begin restocking poultry farms that had been struck by ... in Burma have reported that farms affected by bird flu ... of birds and poultry feed, while keeping such areas under ... bird flu outbreak since April 6th.The first outbreak of the ...
... warning to the public that they could end up buying ... , , Drugs such as Viagra, Tamiflu, Prozac and Valium, ... to be fakes or contaminated. ,Nigel Strick, the ... a prescription can turn out to be extremely ...
... High Court ruled on Thursday in favour of a ... Westville prisons department// must immediately remove restrictions on free ... ,The case was brought on behalf of ... prisoners and the Treatment Action Campaign stated that the ...
... The reason the MRSA superbug is so prevalent is because ... published in the British Journal of Nursing//. The study found ... in excess of the permissible 82 percent bed occupancy rates ... ,Researchers from the University of Ulster said that the ...
... burgers, fries and ice cream. Want a girl? Then go on ... according to John Roche, a scientist at New Zealand's dairy research ... mammal will hold true across the board," he said. ... 18-year research project from 1986 to 2004. ,They found ...
... country today called for mass screening to identify people prone ... national stroke prevention policy. // ,On the eve ... popular myths about strokes -- widely and wrongly believed to ... ,"Unlike heart attacks, people know very little about strokes. ...
Cached Medicine News:Health News:Does Weight of the Mother Determine the Sex of the Baby? 2
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Medicine Products: